Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00459-X/fulltext?dgcid=hubspot_email_conferencealerts_esmo23&utm_campaign=conferencealerts&utm_medium=email&_hsmi=278989396&_hsenc=p2ANqtz-90ab4dzjhBbFw3befvapEgnn5wLeMk39LUDgFYuqv5xHdGMYSFQrTcxPK3-GIMFC8C8YTqWJWG9fC53P4DDHMtZbDOBw&utm_content=278989396&utm_source=hs_email